CompletedNot Applicable

Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin

France17 participantsStarted 2019-06-28

Plain-language summary

Our study evaluates the efficacy of IGIV treatment in PPS on clinical (walking and pain) and isokinetic (muscle strength) criteria, on patients with PS at Montpellier's Hospital

Who can participate

Age range30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of PPS * Pre- and post-therapeutic evaluation carried out * Data transcribed in the computerized patient file Exclusion Criteria: * No walking patient

What they're measuring

Muscular strength

Timeframe: 5 months

Trial details

NCT IDNCT04004390

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-01

View on ClinicalTrials.gov More Post-Poliomyélitis Syndrom trials